FMT
SCLN

First Mercantile Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

First Mercantile Trust’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,159
Closed -$19K – 1116
2015
Q1 		$19K Sell
2,159
-1,254
-37% -$9.99K ﹤0.01% 1026
2014
Q4 		$30K Buy
+3,413
New +$27.6K ﹤0.01% 995

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

First Mercantile Trust's SCLN Position: Q2 2015 in Review

First Mercantile Trust sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2015, closing a stake of 2,159 shares — an estimated $19K sold.

First Mercantile Trust first reported a position in SCLN in Q4 2014 and held it in 2 quarters. The position peaked at $30K in Q4 2014. 146 funds tracked by Wall St. Rank hold SCLN as of Q2 2015.

  • First Mercantile Trust reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • First Mercantile Trust sold 2,159 Sciclone Pharmaceuticals Inc shares in Q2 2015, an estimated $19K.
  • First Mercantile Trust first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 2 quarters.
  • First Mercantile Trust's Sciclone Pharmaceuticals Inc position peaked at $30K in Q4 2014.
  • 146 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2015.

Based on First Mercantile Trust's 13F filing for Q2 2015, filed 10 Aug 2015.